Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of ponatinib versus imatinib with reduced-intensity chemotherapy in newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia
CTR20191887Phase 3Active
- Sponsor
- Millennium Pharmaceuticals
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ponatinib, imatinib in acute lymphoblastic leukemia (ALL), sponsored by Millennium Pharmaceuticals. Started Jul 2020; status: active.
02
Drugs
ponatinibimatinib
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on CTR20191887.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20191887.